Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-25-006012
Filing Date
2025-10-08
Accepted
2025-10-08 20:55:08
Documents
1
Period of Report
2025-10-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8835
  Complete submission text file 0000919574-25-006012.txt   10481
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 700 CANAL STREET 2ND FLOOR STAMFORD CT 06902
Business Address 700 CANAL STREET 2ND FLOOR STAMFORD CT 06902 2035163690
Parkman Healthcare Partners LLC (Reporting) CIK: 0001777015 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39594 | Film No.: 251383460